SAN CARLOS, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that it will present ...
This poster will present strategies to early recognize and prevent side effects in oligonucleotide-treated patients through immune stimulation via the TLR9 pathway. This pathway, which has the ...
Agendia to Present Five Posters Demonstrating the Expanding Clinical Utility of MammaPrint + BluePrint at the 2025 San Antonio Breast Cancer Symposium New data from the ongoing FLEX Study highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results